1. Home
  2. MIND vs ATYR Comparison

MIND vs ATYR Comparison

Compare MIND & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

HOLD

Current Price

$7.62

Market Cap

83.4M

Sector

Industrials

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.73

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIND
ATYR
Founded
1987
2005
Country
United States
United States
Employees
N/A
58
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.4M
73.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MIND
ATYR
Price
$7.62
$0.73
Analyst Decision
Hold
Analyst Count
0
8
Target Price
N/A
$4.20
AVG Volume (30 Days)
155.8K
998.5K
Earning Date
04-21-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.08
N/A
P/E Ratio
$22.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.45
$0.64
52 Week High
$14.50
$7.29

Technical Indicators

Market Signals
Indicator
MIND
ATYR
Relative Strength Index (RSI) 42.62 36.57
Support Level $7.61 $0.67
Resistance Level $9.26 $0.85
Average True Range (ATR) 0.69 0.05
MACD 0.01 -0.01
Stochastic Oscillator 1.21 11.12

Price Performance

Historical Comparison
MIND
ATYR

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: